These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3820901)

  • 1. [A case of invasive bladder carcinoma cured by combined cisplatin and radiation therapy].
    Lee K; Egawa S; Sawamura M; Kadowaki K; Ishibashi A
    Nihon Hinyokika Gakkai Zasshi; 1986 Oct; 77(10):1640-2. PubMed ID: 3820901
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined cisplatin and radiation therapy in patients with invasive bladder cancer].
    Mori Y; Arima M; Shimada K; Shima H; Terakawa T; Yabumoto H; Tsujimoto S; Hosokawa S; Ogino T; Fujisue H
    Nihon Hinyokika Gakkai Zasshi; 1987 Aug; 78(8):1345-53. PubMed ID: 3325677
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with combined cisplatin and radiation therapy for advanced urinary tract transitional cell carcinoma].
    Yoshioka T; Utsunomiya M; Itoh H; Itatani H; Namiki M
    Nihon Hinyokika Gakkai Zasshi; 1987 Mar; 78(3):518-24. PubMed ID: 3656856
    [No Abstract]   [Full Text] [Related]  

  • 4. Neoadjuvant intravenous cisplatin for T2-4NxMo bladder cancer.
    Raghavan D; Pearson B; Duval P; Rogers J; Watt H; Tynan A
    Prog Clin Biol Res; 1988; 260():561-70. PubMed ID: 3362905
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study.
    Einstein AB; Wolf M; Halliday KR; Miller GJ; Hafermann M; Lowe BA; Meyers FJ; Leimert JT; Crawford ED
    Urology; 1996 May; 47(5):652-7. PubMed ID: 8650861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
    Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W
    J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined cisplatin and radiation therapy for advanced bladder cancer.
    Matsushima M; Tajima M; Kase T; Harada M; Takanami M; Yagishita T; Sawamura Y; Shirai M; Kaneko I; Kuwashima A
    Urol Int; 1991; 47 Suppl 1():138-42. PubMed ID: 1949371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bladder carcinoma].
    Lycklama à Nijeholt AA
    Ned Tijdschr Geneeskd; 1992 Jun; 136(23):1097-102. PubMed ID: 1603169
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiotherapy and chemotherapy in locally advanced bladder cancer.
    Jakse G; Frommhold H
    Eur Urol; 1988; 14 Suppl 1():45. PubMed ID: 3181245
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.
    Simon SD; Srougi M
    Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415
    [No Abstract]   [Full Text] [Related]  

  • 12. Organ conservation in deeply invasive bladder cancer.
    Fair WR
    Prog Clin Biol Res; 1991; 370():119-26. PubMed ID: 1924440
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of locally advanced bladder cancer by hyperfractionated radiotherapy and chemotherapy.
    Jakse G; Frommhold H
    Prog Clin Biol Res; 1988; 260():431-6. PubMed ID: 3129732
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternative therapies for bladder carcinoma.
    Marshall M; Price SE; Barnhouse DH; Powell JR
    Pa Med; 1987 May; 90(5):76-8. PubMed ID: 3587987
    [No Abstract]   [Full Text] [Related]  

  • 15. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined radiotherapy, chemotherapy and surgery in the management of invasive bladder cancer.
    Jakse G; Frommhold H
    Prog Clin Biol Res; 1988; 269():591-600. PubMed ID: 3393556
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of combination therapy with intravesical instillation of doxorubicin and low-dose radiation for bladder cancer. Comparison with Instillation of Doxorubicin alone.
    Kagawa S; Maebayashi K; Kurokawa K; Uyama T; Moriwaki S
    Urology; 1981 Nov; 18(5):478-81. PubMed ID: 7314339
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma.
    Achkar T; Parikh RA
    Urol Clin North Am; 2018 May; 45(2):257-266. PubMed ID: 29650141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive bladder cancer--where do we go from here?
    Waters WB
    J Urol; 1996 Jun; 155(6):1910-1. PubMed ID: 8618285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.